The extracytoplasmic assembly of the Dot/Icm type IVb secretion system (T4SS) of 25 Legionella pneumophila is dependent on correct disulfide bond (DSB) formation catalyzed by a 26 novel and essential disulfide bond oxidoreductase DsbA2 and not by DsbA1, a second 27 nonessential DSB oxidoreductase. DsbA2, which is widely distributed in the microbial world, is 28 phylogenetically distinct from the canonical DsbA oxidase and the DsbC protein disulfide 29 isomerase (PDI)/reductase of Escherichia coli. Here we show that the extended N-terminal 30 amino acid sequence of DsbA2 (relative to DsbA proteins) contains a highly conserved 27 31 amino acid dimerization domain enabling the protein to form a homodimer. Complementation 32 tests with E. coli mutants established that L. pneumophila dsbA1, but not dsbA2, restored 33 motility to a dsbA mutant. In a protein folding PDI detector assay strain, dsbA2, but not dsbA1, 34
INTRODUCTION 49
Legionella pneumophila and related species reside in aquatic environments as obligate 50 intracellular parasites of amoebic hosts (1, 2). When transmitted to susceptible humans via 51 aerosols, these bacteria can cause an acute pneumonia known as Legionnaires' disease (LD) 52 (3, 4). Since human to human transmission does not occur with LD, there is little opportunity for 53 evolution of virulence or for development of antibiotic resistance. Like many aquatic 54 microorganisms, L. pneumophila displays a dimorphic life cycle, alternating between vegetative 55 replicative intracellular bacteria and planktonic terminally differentiated cysts that are highly 56 infectious and resilient to environmental stresses (5, 6, 7, 8). Both ultrastructural and proteomic 57 analyses of the transition to cyst forms indicate substantial remodeling of the cell envelope and 58 the heightened-infectivity suggests the type IVb Dot/Icm secretion system (T4SS), the major 59 virulence determinant, has become fully functional (7, 9, 10, 11). Since much of the cell 60 remodeling occurs extracytoplasmically, we have been investigating proteins that participate in 61 these processes. These studies led to identification of disulfide bond oxidoreductase DsbA2, 62 that in addition to essential functions, seemed to be required for proper assembly or function of 63 the Dot/Icm T4SS (10). Phylogenetic analysis revealed that DsbA2 formed a distinct clade from 64
DsbA and was broadly distributed in the microbial world from environmental species to nearly all 65 microbial pathogens expressing T4SSs (10). 66
The DSB oxidoreductase family is part of the thioredoxin (TRX) super family of proteins, 67 which are defined by the presence of one or more thioredoxin folds (12). These enzymes 68 participate in disulfide bond formation through a conserved Cys-X-X-Cys (CXXC) active site 69 motif, and can either reduce or oxidize target substrates. DsbA is maintained in the oxidized 70 (disulfide) form by membrane spanning DsbB partner which delivers reducing equivalents from 71
DsbA into the electron transport chain via quinone reduction (13, 14) . Similarly, DsbC and 72
DsbG are maintained in the reduced (thiol) form by DsbD which transfers reducing equivalents 73 from the cytoplasmic thioredoxin/thioredoxin reductase system across the cytoplasmic 74 on October 21, 2017 by guest http://jb.asm.org/ Downloaded from membrane to these periplasmic partners (15, 16, 17) . Separation of the two systems is 75 considered important to avoid futile cycling of reducing equivalents and this is accomplished 76 through the high affinity of DsbD for homodimeric DsbC and DsbG, which are poor substrates of 77 DsbB (15, 18, 19) . While DsbA catalyzes the formation of consecutive disulfide bonds in 78 nascent polypeptides entering the periplasm, DsbC, a protein disulfide isomerase (PDI), is 79 thought to repair inappropriate disulfides or introduce nonconsecutive disulfide bonds through a 80 process of reduction and re-formation of disulfide bonds to aid correct protein folding (15, 19, 81 20) . It is generally believed that once correct disulfide bonds are formed, the rapid folding of 82 proteins, their interactions with periplasmic chaperones or other assembly systems protects 83 these bonds from further redox action (21). 84
As noted previously, the genes encoding DsbC and DsbG are absent from the genomes 85 of DsbA2-expressing species and some like Coxiella burnetii also lack DsbA (10). In contrast to 86 dsbA mutants in other bacteria, including pathogens (17, 22), we showed that dsbA1 mutants of 87 L. pneumophila were indistinguishable from wild type parental strains for infectivity (amoeba and 88
HeLa cell models), motility and were without correlating phenotypes, suggesting that DsbA2 89 likely plays a greater role in managing disulfide bonding and protein folding (10). We also 90
showed that expression of a mutant DsbA2 (P198T) protein in L. pneumophila produced a 91 dominant negative effect on DsbA2 function, resulting in loss of motility and infectivity; the latter 92 traced to a functional defect in the Dot/Icm secretion apparatus (10). Based on DsbA2 existing 93 as a mixture of oxidized and reduced forms in the periplasm of L. pneumophila and together 94 with the ability of DsbA2P198T mutant protein to form stable disulfide bonds with substrate 95 proteins, including the cysteine containing components (DotG and DotC) of the core Dot/Icm 96 structure, we concluded that DsbA2 was functionally similar to DsbA in delivering disulfide 97 bonds to nascent polypeptides (10). 98
Here we show that the extended N-terminal amino acid sequence of DsbA2 (compared 99 to DsbA) contains a highly conserved dimerization domain enabling DsbA2 to exist as a 100 on October 21, 2017 by guest http://jb.asm.org/ Downloaded from DsbA2LDN, minus the leader sequence and dimerization domain was created using primer 126 pairs DsbA2LDNNdeI (5'-GGAATTCCATATGGCCGCAATTCAGGAAAAT) and 127 DsbA2expBamHI (5'-TTAGATGGATCCTTAATTGCCAGCCGCC). The amplicon was cloned 128 into pET15b and expressed in the BL21 strain. All genetic constructs were verified by DNA 129 sequencing and protein expression was determined by SDS-PAGE and immunoblot with anti-130 DsbA2 serum (10). DsbA2LDN was purified by nickel affinity chromatography (Novagen 131 (Madison, WI) as previously described (10). The molecular mass for DsbA2 and DsbA1 (ca 3 132 mg/ml protein) were estimated by gel filtration in 50 mM Tris-HCL,100 mM NaCl at pH 8 on a 133 and monomer were subjected to SDS-PAGE. The proteins were transferred to nitrocellulose 142 and developed with DsbA2-specific antibody diluted 1:10 000 in PBS with 0.1% Tween 20 as 143 previously described (10, 25). 144
Complementation studies. E. coli wild type (JCB570) and a dsbA mutant (JCB571) 145 were kindly provided by Dr. J. C. Bardwell. The plasmid pBC containing either the coding 146 sequence of dsbA1, dsbA2, or empty vector were transformed into the E. coli strains and 147 selected by chloramphenicol resistance. To construct an in frame deletion of the dimerization 148 domain of DsbA2 (DsbA2N), a vector-free strategy was employed using overlapping primers 149 supplemented with 1 mM IPTG were prepared and 2 μl of cell suspension was inserted into the 156 middle of the plate. The LB plates were incubated overnight at 30°C and motility was assessed 157
by measuring the diameter of spreading bacterial growth and reported as percent of the WT 158 control. Motility assays were performed in triplicate and the results from representative plates 159 are presented. 160 PDI Detector assay. The PDI detector assay utilizes the TEM1 β-lactamase of pBR322 161
with an engineered non-consecutive disulfide bond (cysteine residues added S81C and T108C) 162 that requires disulfide bond isomerase activity to be properly folded in the E. coli periplasm (20) . Strains kindly provided by Dr. Bardwell and listed in Table 1 of insulin reduction and specific activity were determined in triplicate using the enzyme kinetics 181 program as previously described (10). The results from a typical experiment are presented. 182
Isomerization assay. TEM1 β-lactamase (WT and PDI detector mutant enzyme Bla and 183 MBla, respectively) were obtained from spent culture supernatants of strains RGP663 and 184 RGP665, respectively, following overnight growth in LB medium. Supernatants were 185 concentrated by spin columns (12 ml concentrated to 0.5 ml) (Amicon Ultracel 10k). Bla activity 186 was tested by spotting 5 μl of concentrated supernatant onto nitrocefin impregnated paper disks 187 (Becton Dickinson). The relative concentration of Bla in each fraction was determined by SDS-188 PAGE following staining with Coomassie brilliant blue. For the PDI assay, either purified 189 leaderless H 6 -tagged DsbA1 (6.9 mg/ml) or H 6 -DsbA2 (3 mg/ml) was added to concentrated 190 culture supernatant from strain RGP665 in ratios of 1:5, respectively, and incubated at 37 and RNA concentrations were determined using a NanoDrop® ND-1000 spectrophotometer 220 (Nanodrop Technologies, USA). First-strand cDNA was generated using SuperScript First-221
Strand synthesis system for RT-PCR (Invitrogen, CA). When the RT reaction was completed 222 samples were adjusted to 200 μl with molecular biology water. Phylogenetic trees were generated by multiple sequence alignment of unedited DsbA2 238 sequences using CLUSTALW. Analyses were further refined by BLASTP search using the 239 highly conserved dimerization domain sequence (SLSDAQKKEIEKVIHDYLINNPEVLLEASQA). 240
241

RESULTS
242
Previous phylogenetic analysis of DsbA2 clade indicated that this group has diverged 243 from the DsbA lineage of disulfide bond oxidoreductases (10). Comparisons of the structures of 244
DsbA2, DsbA and DsbC shows that DsbA2 contains an additional 56 amino acids (86 total) from 245 the N-terminus to the CXXC motif compared with 31 for DsbA and 107 for DsbC. A refined 246 BLASTP search using the dimerization domain region depicted in Figure 1A revealed a 27 aa 247 sequence (bolded in Figure 1A ) present in all the bacterial species expressing DsbA2 listed in 248 Table 2 . Moreover, this sequence is more discriminating than searches with the whole protein or 249 the C-terminal DsbA-related sequences used previously (10). Bordetella pertussis, which has a T4SS (PTL) and expresses DsbA/DsbC system similar to the 258
In addition, the spacing between the CXXC motif and the resolving cis-proline motif is 260 conserved between DsbA2 and DsbA compared with DsbC. Finally, as highlighted in Figure 1B , 261 the first amino acid to the N-terminus of the cis-proline in DsbA2 (threonine) is similar to DsbC 262
and not DsbA which substitutes valine. Further genomic analysis using E. coli DsbC and DsbG 263 amino acid sequences in the BLASTP searches revealed that the genera expressing DsbA2 264 listed in Table 2 also lacked orthologues of DsbC and DsbG. Our previous studies showed that 265 L. pneumophila ΔdsbA1 was indistinguishable from the wild type strain for motility and infectivity 266 for amoeba and HeLa cells, and in close relative Coxiella burnetii, dsbA1 is completely absent 267 from sequenced genomes (10). While there is plenty of precedent for interchangeability of 268 DsbA and DsbC functions in E. coli (18, 19), we investigated whether DsbA2 represents a 269 functional equivalent of DsbC or if equilibrium of monomers and homodimers is responsible for 270 the apparent bifunctional phenotype and thus a variation of the E. coli DsbA/DsbC paradigm. 271
DsbA2 exists as a homodimer in E. coli and L. pneumophila. To test whether 272
DsbA2 exists as a mixture of monomers and dimers, size exclusion chromatography was 273 employed. For this study, H 6 -tagged DsbA1 and DsbA2 were treated with iodoacetamide to limit 274 formation of spurious disulfides prior to nickel interaction chromatography. Each protein was 275 applied to a calibrated gel filtration column and as seen in Figure 2A was unnecessary (data not presented). To ensure that the homodimeric form was not an 280 artifact generated in E. coli, we applied osmotic shockates from L. pneumophila similarly treated 281 with iodoacetamide over the same calibrated column and DsbA2 eluted as the dimer (see 282 Figure 2C ). The elution of DsbA2 as a single peak suggests that if the monomer form is present 283 in L. pneumophila, it is below the limit of detection in our assay. 284
Legionella pneumophila dsbA1and DsbA2N, but not dsbA2 restores motility to a 285 dsbA mutant of E. coli. In E. coli, DsbA is required for disulfide bond formation in the flagellar 286 P-ring protein (FlgI), which is necessary for motility in soft agar (27). As seen in Figure 3A , wild 287 type E. coli strain JCB570 is motile in 0.4% soft agar, whereas ∆dsbA mutant strain JCB571 is 288 not. We introduced L. pneumophila dsbA1 and dsbA2 expressed from pBC plasmids into 289 JCB571 to test whether expression of these proteins could restore motility. As seen in Figure  290 3A, dsbA1 complemented motility to ~60% of wild type (diameter of spreading growth), whereas 291 dsbA2 did not, consistent with the general view that dimeric proteins, such as DsbC, are poor 292 substrates of the E. coli DsbB (18,19, 28). We next removed the dimerization domain of DsbA2 293 (DsbA2N) by an in frame deletion that retained the signal sequence as depicted in Figure 1A to 294 create the monomer. The DsbA2N monomer was confirmed by gel filtration. Expression of 295 dsbA2N in JCB571 restored motility to nearly wild type activity (>70%) of control (see Figure  296 3B). While growth rate differences might account for the partial complementation in our studies, 297 these were not apparent and more likely; these differences reflect different efficiencies of DsbA1 In E. coli, DsbA catalyzes disulfide bonding between consecutive cysteine residues as the 302 nascent polypeptide enters the periplasm (26). For those proteins for which non-consecutive 303 disulfide bonding is required for proper folding, consecutive disulfide bonds must be reduced 304 and then reformed between non-consecutive cysteine residues. In E. coli, the protein disulfide 305 isomerase DsbC catalyzes this reaction (20). In our previous studies, we noted that some of the 306 proteins captured by DsbA2 contained an odd number of cysteine residues and prediction 307 software analyses suggested that some of these might be non-consecutive (10). Since DsbA2 308
exists as a homodimer, we tested the possibility that DsbA2 might complement a dsbC mutant 309 of E. coli by restoring PDI activity. To test this hypothesis, dsbA2, dsbA2N and dsbA1 were 310 cloned into an E. coli strain mutant for dsbC and containing a pPDI detector system (20). In this 311 system, a TEM β-lactamase (Bla) which naturally contains two cysteine residues at positions 52 312 and 98 that are not required for biological activity was engineered to contain an additional two 313 cysteine residues (81 and 108) positioned so that DsbA will introduce consecutive disulfide 314 bonds and produce an inactive enzyme (20). In the presence of DsbC, biological activity is 315 restored by PDI activity (20). In this PDI detector assay, only dsbA2 expression restored 316 ampicillin resistance to nearly wild type DsbC control levels at 2 or 3 g/l of drug (see Figure 4A  317 and B). In contrast, DsbA1 (depicted in Figure 4A and 4B), DsbA2LDN ( Figure 4A ) and DsbA2N 318 ( Figure 4B ) failed to complement in the PDI detector assay. The potent PDI activity displayed by 319
DsbA2 in E. coli also suggests that DsbA2 is an efficient substrate of the DsbD reductase 320 system, perhaps tipping the balance in favor of PDI/reductase activity over oxidase activity. To 321 confirm the redox status of DsbA2 and DsbA2N in E. coli, we used the thiol alkylating agent 322 MalPEG5000 to alkylate free thiols and those thiols reactive with MalPEG result in an increased 323 mass of 5000 daltons per cysteine residue. As seen in Figure 5 , whole E. coli bacteria 324 
As seen in Figure 6 , the Bla activity of MBla in concentrated spent culture supernatants is below 337 the level of detection over the course of the assay. Incubation of DsbA2, but not DsbA1 with 338
MBla efficiently corrected disulfide bonding and catalyzed protein folding as noted by a gain in 339 enzyme activity with nitrocefin. Compared with the WT Bla similarly concentrated from culture 340 supernatants, near equivalent activity was obtained. These studies were repeated several times 341 and a representative experiment presented. These studies confirm the biological assay for PDI 342 activity for DsbA2. 343
Insulin reduction assay of DsbA1, DsbA2 and DsbA2LDN. An insulin reduction assay 344
is often used to demonstrate thioredoxin like activity of DSBs (13, 30). This assay can 345 distinguish between strong oxidases like DsbA and reductases such as thioredoxin by both the 346 time to reduction and by the rate of insulin precipitation resulting from the reduction of its 347 disulfide bond (31). In this regard, we previously demonstrated that DsbA2 was similar to 348 thioredoxin in this assay (10). As seen in Figure 7 dsbA1 was expressed two-fold higher in stationary phase than exponential phase, whereas 358 dsbA2 expression in stationary phase was increased more than five-fold. We had previously 359 reported that DsbA2 protein levels were more abundant in differentiated cyst forms than 360 stationary phase forms (7) and based on transcript levels; both dsb genes appear to be up-361 regulated in stationary phase. 362
Redox status of DsbA2 is unchanged through cyst phase. In Gram negative 363
bacteria, DsbA is maintained fully oxidized by DsbB, while DsbC is maintained fully reduced by 364 the DsbD system. We previously reported that DsbA2 existed as a mixture of oxidized and 365 reduced forms in L. pneumophila during stationary phase (10). We examined bacteria harvested 366 from stationary phase as well as from water differentiated metabolically dormant forms (7). 367
Collected bacteria were TCA precipitated and subjected to AMS alkylation, which adds ~500 368 daltons to free cysteine thiol residues which can then be observed as a shift in apparent mass 369 by SDS-PAGE and immunoblot. As seen in Figure 9 , even after suspension in tap water for 370 several days, DsbA2 exists as a mixture of thiols and disulfides in the cyst-like forms. Since 371 these forms are nearly dormant metabolically and exhibit no measurable respiration rate (7), it is 372 not know how the mixture is maintained under these conditions. The results of our studies show that DsbA2 of L. pneumophila, which contains a 56 378 amino acid N-terminal extension relative to DsbA of E. coli, forms a homodimer in L. 379 pneumophila and displays protein disulfide isomerase activity in both in vivo and in vitro assays. 380
We previously reported that DsbA2 behaved similarly to DsbA by catalyzing the formation of 381 disulfide bonds in secreted proteins of L. pneumophila (10). Consistent with DsbA-like activity, 382 a DsbA2 cis-proline (P198T) mutant protein formed stable disulfide cross-linked complexes with 383 substrate proteins (10). Only the disulfide is capable of capturing substrate proteins (26). 384
Previous studies found that L. pneumophila DsbA1 was dispensable for growth, motility, and 385 infectivity in cell-based assays; and that this gene is naturally absent from the genome of C. 386 burnetii which also expresses a dsbB (10). Taken together, these findings suggest that the 387 DsbA2 lineage may be naturally bifunctional and therefore functionally unique from the 388 DsbA/DsbC paradigm so well characterized in E. coli. 389
In support of this notion, we determined that DsbA2 was present as a mixture of reduced 390 thiol and disulfide forms in vivo, which contrasts with DsbA and DsbC which are mostly oxidized 391 and reduced, respectively (28). We determined by gel filtration that the mixture of oxidized and 392 reduced forms was not due to equilibrium of monomer and dimer forms. Our studies do not rule 393 out the possibility that each arm of the DsbA2 dimer might contribute to the mixture, one as the 394 disulfide and the other as the free thiol. Our studies suggest that structural differences within the 395 thioredoxin folds of DsbA2 might render them more accessible to the DsbB oxidases of L. 396 pneumophila. In this regard, L. pneumophila expresses two alleles, DsbB1 and DsbB2 also 397 known as LidJ (32) that show sequence divergence from E. coli DsbB. As previously reported, 398 L. pneumophila also expresses two alleles of DsbD (10). We suggest that these competing 399 oxidases and reductases interact with DsbA2 at differing efficiencies to maintain an equilibrium 400 between oxidized and reduced forms. coli DsbC-DsbA chimera. We suggest that key amino acid differences in the cis-proline domain 411
(TPA versus VPA in DsbA), similar to DsbC may favor PDI reductase activity. In the insulin 412 reductase assay, DsbA2 and even the DsbA2N monomer exhibited reductase characteristics 413 more similar to DsbC than to DsbA (see Figure 7) . Thus, the DsbA2 lineage appears to be a 414 unique adaptation which combines both oxidase and reductase functions into a single protein in 415 situ. To explore the basis for this adaptation, we have replaced the E. coli dsbB and dsbD genes 416 with alleles from L. pneumophila and future studies will likely show that structural divergence in 417 the two DsbD alleles may affect reducing efficiency of DsbA2. DsbA/DsbC system is required to accelerate correct disulfide bond formation to enable protein 438 folding to keep pace with cell division. This possibility seems to be supported by growth rate 439 differences noted with E. coli strains carrying single mutations in dsbA and double mutations 440 (dsbA dsbC and dsbA dsbD) (36). In this regard, DsbA accelerates disulfide bond formation 441 between consecutive cysteines as most nascent polypeptides enter the periplasm (15, 37, 38). 442
However, in other proteins, disulfide bonds may form after the protein has entered the periplasm 443 (37) or require correction of mispaired disulfides by DsbC (21). We suspect that in those slow 444 growing bacteria expressing DsbA2, such as L. pneumophila, disulfide bonds might be 445 introduced after proteins enter the periplasm, which is supported by the efficiency and diversity 446 of proteins captured by the DsbA2P198T mutant protein (10). It follows that the apparent 447 essentiality of dsbA2 is due to both its bifunctional nature as well as to an absence of any 448 backup system to repair miss-oxidized proteins that would accumulate to toxic levels in the 449 periplasm. We also noted that over expression of the DsbA2P198T mutant protein rendered L. 450 pneumophila non-infectious by interfering with assembly and function of the T4SSs (10). Since 451 dsbA2 was also essential in strains with mutations in dot/icm structural genes, we concluded 452 that DsbA2 must be associated with proper folding of other proteins whose functions might also 453 be essential including OmpS porin and periplasmic Hsp60 (10, 39, 40, 41 This is a partial list from more than 60 genomes identified by BLASTP with DsbA2 and 666 the 27 amino acid dimerization domain sequences depicted in Figure 1A . For DsbA1, 667 DsbB, DsbD, DsbC, DsbG, and CcmG, the E. coli protein sequences were used for the 668 searches against each genus. The presence or absence of a type IV secretion system 669 (T4SS) was determined from the literature. The question mark for Fransicella tularensis 670
indicates that the system may be incomplete. CcmG is a thioredoxin like periplasmic 671 enzyme associated with cytochrome c maturation. 
